AbbVie
ABBV
#32
Rank
HK$2.950 T
Marketcap
HK$1,670
Share price
-1.20%
Change (1 day)
15.72%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): HK$16.06

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$16.11. In 2025 the company made an earnings per share (EPS) of HK$18.74 a decrease over its 2024 EPS that were of HK$18.98.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$16.06-14.29%
2025HK$18.74-1.26%
2024HK$18.98-11.86%
2023HK$21.53-58.95%
2022HK$52.452.49%
2021HK$51.18121.58%
2020HK$23.10-44.7%
2019HK$41.7745.84%
2018HK$28.649.72%
2017HK$26.10-9.54%
2016HK$28.8516.28%
2015HK$24.81184.1%
2014HK$8.73-57.15%
2013HK$20.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.26-36.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.15 1,272.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.45 604.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$73.26 354.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.67 233.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.89 73.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.45 237.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$30.45 88.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$52.57 226.30%๐Ÿ‡บ๐Ÿ‡ธ USA